Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
NASDAQ:NAGE

Niagen Bioscience Q2 2025 Earnings Report

Niagen Bioscience logo
$3.08 +0.03 (+0.98%)
Closing price 04:00 PM Eastern
Extended Trading
$3.04 -0.04 (-1.23%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Niagen Bioscience EPS Results

Actual EPS
$0.04
Consensus EPS
$0.02
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

Niagen Bioscience Revenue Results

Actual Revenue
$31.12 million
Expected Revenue
$28.55 million
Beat/Miss
Beat by +$2.57 million
YoY Revenue Growth
N/A

Niagen Bioscience Announcement Details

Quarter
Q2 2025
Date
8/6/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Niagen Bioscience Earnings Headlines

Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Recommendation of "Buy" by Brokerages
August 10 at 3:33 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30952251
HC Wainwright Issues Pessimistic Forecast for NAGE Earnings
August 9 at 1:29 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30949389
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
August 11 at 1:00 AM  |  Porter & Company (Ad)
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative?
August 8 at 1:19 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/does-niagen-biosciences-nage-walmart-151315634.html
HC Wainwright Cuts Earnings Estimates for Niagen Bioscience
August 8 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30947754
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value
August 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/niagen-bioscience-nage-aging-study-061050368.html
See More Niagen Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Niagen Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Niagen Bioscience and other key companies, straight to your email.

About Niagen Bioscience

Niagen Bioscience (NASDAQ:NAGE) is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

View Niagen Bioscience Profile
Earnings Tools